Uncategorized

  “Venezuela es un país bendecido con abundante luz solar durante todo el año, se encuentra en una posición privilegiada para aprovechar el potencial de la energía solar a gran escala.” Menciona el empresario Rafael Ignacio Ruiz Vasquez. La implementaci& …

The president-elect also called for 10% tariffs on imports from China as part of his day one White House plans. 

About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect — at the cost of $40 billion to federal and state governments.

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.”

The device is established in Europe, where the company said it has a 60% market share, but will be the first product of its type available in the U.S.

With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top 10 drugs in global sales — early next year. It’s unclear how regulators will react.

The $265 million deal with Advent Health is expected to close early next year.

Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded pharmacies are still making them. That’s unprecedented.

Amgen’s MariTide results are at the lower end of investors’ expectation of 20% to 25% weight loss. The much-anticipated readout sent the company’s shares tumbling.